Severity and Cost of RSV Hospitalization Among US Preterm Infants Following the 2014 American Academy of Pediatrics Policy Change.

Krilov, Leonard R; Forbes, Michael L; Goldstein, Mitchell; Wadhawan, Rajan; Stewart, Dan L

Krilov, Leonard R; Forbes, Michael L; Goldstein, Mitchell; Wadhawan, Rajan; Stewart, Dan L.

Afiliação

Krilov LR; Department of Pediatrics, NYU Langone Hospital - Long Island and the NYU Long Island School of Medicine, Mineola, NY, USA. Leonard.Krilov@nyulangone.org.
Forbes ML; Department of Pediatrics, Akron Children's Hospital, Akron, OH, USA.
Goldstein M; Department of Pediatrics, Loma Linda University Children's Hospital, Loma Linda, CA, USA.
Wadhawan R; Department of Pediatrics, AdventHealth for Children, Orlando, FL, USA.
Stewart DL; Department of Pediatrics, Norton Children's Hospital and University of Louisville Hospital, Louisville, KY, USA.

Infect Dis Ther ; 10(Suppl 1): 27-34, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33656650

Palavras-chave

American Academy of Pediatrics; Cost; High-risk preterm infants; Immunoprophylaxis; National Perinatal Association; Palivizumab; RSV hospitalization; RSV morbidity; Respiratory syncytial virus; Severity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article